Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Tech giants report mixed earnings amid AI investments and market shifts, as Wall Street remains cautiously optimistic about the sector's future.
Equinix trims revenue outlook, eBay beats Q3 but sees margin compression and macro headwinds.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Tech giants report mixed earnings amid AI investments and market shifts, as Wall Street remains cautiously optimistic about the sector's future.
Equinix trims revenue outlook, eBay beats Q3 but sees margin compression and macro headwinds.